Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for
the management of malignant and benign neoplasms. Detecting circulating DNA in cancer …

Gastric cancer is a deadly malignancy afflicting close to a million people worldwide. Patient
survival is poor and largely due to late diagnosis and suboptimal therapies. Disease …

The aim of the present study was to perform a systematic review of published studies to
provide a robust estimation of the use of procalcitonin (ProCT) as a diagnostic marker of …

Cancer initiation and progression is controlled by both genetic and epigenetic events.
Epigenetics refers to the study of mechanisms that alter gene expression without …

Epigenetic alterations contribute significantly to the development and progression of gastric
cancer, one of the leading causes of cancer death worldwide. Epigenetics refers to the …

Gastric cancer is one of the most common gastrointestinal tumor types, and the incidence
and mortality rates are higher in men compared with women. Various studies have revealed …

Background Circulating tumor DNA (ctDNA) has offered a minimally invasive approach for
detection and measurement of gastric cancer (GC). However, its diagnostic and prognostic …

Gastric cancer is in decline in most developed countries; however, it still accounts for a
notable fraction of global mortality and morbidity related to cancer. High-throughput methods …

Gastric cancer (GC) is one of the most common malignant tumors with poor prognosis
worldwide, mainly due to the lack of suitable modalities for population‑based screening and …

Abstract Knowledge about the molecular profile of tumor tissues is crucial to effectively target
cancer cells, because cancer is a genetic disease that involves multiple genetic and …